Purification Method of Extracellular Vesicles Derived from Human T-Cell Leukemia Virus Type 1-Infected Cells without Virions
Viruses · 2024
DOI: 10.3390/v16020249 ↗At a glance
Journal article in Viruses, 2024. Written by Katsumi Kawano and 2 co-authors. Institution: Division of Respirology, Rheumatology, Infectious Diseases and Neurology, Department of Internal Medicine, University of Miyazaki, Kihara 5200, Kiyot…. Major MEDLINE topics: Human T-lymphotropic virus 1, Leukemia, T-Cell, Extracellular Vesicles. Cited 4 times so far (Crossref); 43 references. The full text is freely available (open access, CC BY 4.0). Funded by: JSPS KAKENHI, a Grant for Clinical Research, Miyazaki University Hospital, Clinical Research from Miyazaki University Hospital.
Abstract (original language)
To mediate intercellular communication, cells produce extracellular vesicles (EVs). These EVs transport many biomolecules such as proteins, nucleic acids, and lipids between cells and regulate pathophysiological actions in the recipient cell. However, EVs and virus particles produced from virus-infected cells are of similar size and specific gravity; therefore, the separation and purification of these two particles is often controversial. When analyzing the physiological functions of EVs from virus-infected cells, the presence or absence of virus particle contamination must always be verified. The human T-cell leukemia virus type 1 (HTLV-1)-infected cell line, MT-2, produces EVs and virus particles. Here, we validated a method for purifying EVs from MT-2 cell culture supernatants while avoiding HTLV-1 viral particle contamination. EV fractions were collected using a combination of immunoprecipitation with Tim-4, which binds to phosphatidylserine, and polymer precipitation. The HTLV-1 viral envelope protein, gp46, was not detected in the EV fraction. Proteomic analysis revealed that EV-constituted proteins were predominant in this EV fraction. Furthermore, the EVs were found to contain the HTLV-1 viral genome. The proposed method can purify EVs while avoiding virus particle contamination and is expected to contribute to future research on EVs derived from HTLV-1-infected cells.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Division of Respirology, Rheumatology, Infectious Diseases and Neurology, Department of Internal Medicine, University of Miyazaki, Kihara 5200, Kiyotake, Miyazaki 889-1692, Japan.
- Clinical Laboratory, University of Miyazaki of Hospital, Kihara 5200, Kiyotake, Miyazaki 889-1692, Japan.
ORCID profiles: Kunihiko Umekita
Funding
- JSPS KAKENHI
- a Grant for Clinical Research, Miyazaki University Hospital
- Clinical Research from Miyazaki University Hospital
Cite
APA
Kawano, K., Hashikura, Y., & Umekita, K. (2024). Purification Method of Extracellular Vesicles Derived from Human T-Cell Leukemia Virus Type 1-Infected Cells without Virions. Viruses. https://doi.org/10.3390/v16020249
Vancouver
Kawano K, Hashikura Y, Umekita K. Purification Method of Extracellular Vesicles Derived from Human T-Cell Leukemia Virus Type 1-Infected Cells without Virions. Viruses. 2024. doi:10.3390/v16020249
BibTeX
@article{Kawano2024,
author = {Kawano, Katsumi and Hashikura, Yuki and Umekita, Kunihiko},
title = {Purification Method of Extracellular Vesicles Derived from Human T-Cell Leukemia Virus Type 1-Infected Cells without Virions},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16020249}
}
EUVIMED